---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-016242"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:00:37.054866+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ADC Therapeutics shareholders approve capital range increase and conditional share capital amendments

## Summary
- Shareholders approved amendment to Article 4a to increase capital range (52.4M for, 9.0M against).
- Shareholders approved amendment to Article 4c to increase conditional share capital for financing/acquisitions (52.3M for, 9.0M against).
- Amendments to articles of association became effective immediately upon approval at Nov 11, 2024 special meeting.
- Broker non-votes: none reported for either proposal.

## SEC filing metadata
- accession: 0000950103-24-016242
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010324016242/0000950103-24-016242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010324016242/dp220630_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-016242
- JSON: https://secwatch.observer/filing/0000950103-24-016242.json
- Plain text: https://secwatch.observer/filing/0000950103-24-016242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.